Azitra Quote - AZTR

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.465

Bid

Offer

Volume

3,405

0.00 Day's Range 0.00

0.4264 52 Week Range 68.40

Market Cap

3.546M

Previous Close

0.47

Open

Last Trade

0.47

Last Trade Time

00:42:07

Financial Volume

VWAP

Average Volume (3m)

236,776

Shares Outstanding

7,626,056

Dividend Yield

PE Ratio

-0.28

Earnings Per Share (EPS)

-1.66

Revenue

686k

Net Profit

-12.64M

Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library ... Azitra Inc is an early-stage clinical biopharmaceutical company. The Company is focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. Its platform includes a microbial library comprised of approximately 1,500 bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen its library of strains for drug-like molecules. Its product ATR-12 is a genetically modified strain of S. epidermidis for treating the orphan disease, Netherton syndrome, a chronic and fatal disease of the skin. Its product ATR-04 is a genetically modified strain of S. epidermidis for treating the papulopustular rash. Its product ATR-01 is a human filaggrin protein for treating ichthyosis vulgaris, a chronic, xerotic (abnormally dry), and scaly skin disease. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.azitrainc.com

Headquarters

Wilmington, Delaware, USA

Founded

Azitra Inc is listed in the Pharmaceutical Preparations sector of the American Stock Exchange with ticker AZTR. The last closing price for Azitra was US$0.47. Over the last year, Azitra shares have traded in a share price range of US$ 0.4264 to US$ 68.40.

Azitra currently has 7,626,056 shares in issue. The market capitalisation of Azitra is US$3.58 million. Azitra has a price to earnings ratio (PE ratio) of -0.28.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.015	-3.125	0.48	0.5032	0.4264	166262	0.45826606	CS
4	-0.0908	-16.3368118028	0.5558	0.6	0.4264	161235	0.49678448	CS
12	-0.205	-30.5970149254	0.67	0.6805	0.4264	236776	0.55150053	CS
26	-5.535	-92.25	6	12	0.4264	2085551	3.31725522	CS
52	-43.335	-98.9383561644	43.8	68.4	0.4264	1359505	4.29328178	CS
156	-127.335	-99.6361502347	127.8	155.4	0.4264	953613	4.91663488	CS
260	-127.335	-99.6361502347	127.8	155.4	0.4264	953613	4.91663488	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
BBLUEa Bridgeway Blue Chip ETF	US$ 17.50 (32.98%)	5
EBNDSPDR Bloomberg Emerging Markets Local Bond ETF	US$ 25.00 (25.38%)	23
GENCGencor Industries Inc	US$ 25.99 (21.85%)	4
MSTUT Rex 2X Long MSTR Daily Target ETF	US$ 311.00 (21.14%)	1.55M
SNOYYieldmax Snow Option Income Strategy ETF	US$ 20.93 (19.19%)	1.73k
UMDDProShares UltraPro MidCap 400	US$ 21.95 (-27.15%)	1
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 0.6112 (-24.80%)	69.47M
CATXPerspective Therapeutics Inc	US$ 4.78 (-22.53%)	225.22k
FLMXFranklin FTSE Mexico ETF	US$ 20.00 (-19.61%)	13
ETHDProshares Ultrashort Ether ETF	US$ 25.7316 (-18.16%)	18.31k
MSTZT Rex 2X Inverse MSTR Daily Target ETF	US$ 0.6112 (-24.80%)	69.47M
ETHU2x Ether ETF	US$ 8.73 (18.13%)	11.08M
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 27.85 (2.65%)	8.1M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF	US$ 2.955 (-3.43%)	6.58M
GNSGenius Group Limited	US$ 1.01 (6.32%)	3.56M